サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：非ステロイド性抗炎症薬の世界市場の規模調査：適応症別、投与経路別、流通チャネル別、地域別予測（2022～2028年）
市場調査レポート
商品コード
1105733

非ステロイド性抗炎症薬の世界市場の規模調査：適応症別、投与経路別、流通チャネル別、地域別予測（2022～2028年）

Global Non-steroidal Anti-inflammatory Drugs Market Size study, by Disease Indication by Route of Administration by Distribution Channel and Regional Forecasts 2022-2028.
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
非ステロイド性抗炎症薬の世界市場の規模調査：適応症別、投与経路別、流通チャネル別、地域別予測（2022～2028年）
出版日: 2022年07月12日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の非ステロイド性抗炎症薬市場は、2022～2028年の予測期間中に健全な成長率で推移すると予測されています。

非ステロイド性抗炎症薬（NSAIDs）市場は、世界中で慢性疼痛が増加していること、世界的に高齢者人口が増加していることなどの理由により拡大しつつあります。さらに、関節炎やその他の疼痛関連疾患の有病率の上昇は、予測期間を通じて市場の拡大を促進すると考えられます。しかし、薬剤の副作用が予測期間を通じて市場拡大の妨げとなることが予想されます。

当レポートでは、世界の非ステロイド性抗炎症薬市場について調査分析し、市場力学、業界分析、COVID-19の影響、適応症・投与経路・流通チャネル・地域別市場分析、企業プロファイル等に関する情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界の非ステロイド性抗炎症薬市場の定義と範囲

第3章 世界の非ステロイド性抗炎症薬：市場力学

  • 非ステロイド性抗炎症薬市場の影響分析（2020～2028年）

第4章 世界の非ステロイド性抗炎症薬市場の業界分析

  • ポーターのファイブフォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論
  • 主要投資機会
  • 主要ウィニング戦略

第5章 リスク評価：COVID-19の影響

    • COVID-19が業界に与える全体的な影響の評価
    • COVID-19前とCOVID-19後の市場シナリオ

第6章 世界の非ステロイド性抗炎症薬市場：適応症別

  • 市場スナップショット
  • 世界の非ステロイド性抗炎症薬市場：適応症、性能別-潜在的な分析
  • 世界の非ステロイド性抗炎症薬市場の推定と予測：適応症別（2018～2028年（10億米ドル））
  • 非ステロイド性抗炎症薬市場：サブセグメント分析
    • 関節炎
    • 片頭痛
    • 眼科疾患
    • その他

第7章 世界の非ステロイド性抗炎症薬市場：投与経路別

  • 市場スナップショット
  • 世界の非ステロイド性抗炎症薬市場：投与経路、性能別-潜在的な分析
  • 世界の非ステロイド性抗炎症薬市場の推定と予測：投与経路別（2018～2028年（10億米ドル））
  • 非ステロイド性抗炎症薬市場：サブセグメント分析
    • 経口
    • 外用
    • その他

第8章 世界の非ステロイド性抗炎症薬市場：流通チャネル別

  • 市場スナップショット
  • 世界の非ステロイド性抗炎症薬市場：流通チャネル、性能別-潜在的な分析
  • 世界の非ステロイド性抗炎症薬市場の推定と予測：流通チャネル別（2018～2028年（10億米ドル））
  • 非ステロイド性抗炎症薬市場：サブセグメント分析
    • 病院薬局
    • 小売薬局
    • オンライン薬局

第9章 世界の非ステロイド性抗炎症薬市場：地域分析

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカスナップショット
    • ブラジル
    • メキシコ
  • 世界のその他の地域

第10章 競合情報

  • 主要市場戦略
  • 企業プロファイル
    • Pfizer Inc.
    • Bayer AG
    • GSK plc
    • Dr. Reddy's Laboratories Ltd
    • Viatris Inc
    • Teva Pharmaceutical Industries Ltd.
    • Johnson And Johnson Services, Inc.
    • Merck & Co., Inc.
    • Becton Dickinson & Company
    • Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.)

第11章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Non-steroidal Anti-inflammatory Drugs Market, report scope
  • TABLE 2. Global Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by Region 2018-2028 (USD Billion)
  • TABLE 3. Global Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by Disease Indication 2018-2028 (USD Billion)
  • TABLE 4. Global Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by Route of Administration 2018-2028 (USD Billion)
  • TABLE 5. Global Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by Distribution Channel 2018-2028 (USD Billion)
  • TABLE 6. Global Non-steroidal Anti-inflammatory Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 7. Global Non-steroidal Anti-inflammatory Drugs Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 8. Global Non-steroidal Anti-inflammatory Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 9. Global Non-steroidal Anti-inflammatory Drugs Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 10. Global Non-steroidal Anti-inflammatory Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 11. Global Non-steroidal Anti-inflammatory Drugs Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 12. Global Non-steroidal Anti-inflammatory Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 13. Global Non-steroidal Anti-inflammatory Drugs Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 14. Global Non-steroidal Anti-inflammatory Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 15. Global Non-steroidal Anti-inflammatory Drugs Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 16. U.S. Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 17. U.S. Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 18. U.S. Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 19. Canada Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 20. Canada Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 21. Canada Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 22. UK Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 23. UK Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 24. UK Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 25. Germany Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 26. Germany Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 27. Germany Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 28. RoE Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 29. RoE Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 30. RoE Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 31. China Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 32. China Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 33. China Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 34. India Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 35. India Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 36. India Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 37. Japan Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 38. Japan Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 39. Japan Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 40. RoAPAC Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 41. RoAPAC Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 42. RoAPAC Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 43. Brazil Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 44. Brazil Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 45. Brazil Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 46. Mexico Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 47. Mexico Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 48. Mexico Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 49. RoLA Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 50. RoLA Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 51. RoLA Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 52. Row Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 53. Row Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 54. Row Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 55. List of secondary sources, used in the study of global Non-steroidal Anti-inflammatory Drugs Market
  • TABLE 56. List of primary sources, used in the study of global Non-steroidal Anti-inflammatory Drugs Market
  • TABLE 57. Years considered for the study
  • TABLE 58. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Non-steroidal Anti-inflammatory Drugs Market, research methodology
  • FIG 2. Global Non-steroidal Anti-inflammatory Drugs Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Non-steroidal Anti-inflammatory Drugs Market, key trends 2021
  • FIG 5. Global Non-steroidal Anti-inflammatory Drugs Market, growth prospects 2022-2028
  • FIG 6. Global Non-steroidal Anti-inflammatory Drugs Market, porters 5 force model
  • FIG 7. Global Non-steroidal Anti-inflammatory Drugs Market, pest analysis
  • FIG 8. Global Non-steroidal Anti-inflammatory Drugs Market, value chain analysis
  • FIG 9. Global Non-steroidal Anti-inflammatory Drugs Market by segment, 2018 & 2028 (USD Billion)
  • FIG 10. Global Non-steroidal Anti-inflammatory Drugs Market by segment, 2018 & 2028 (USD Billion)
  • FIG 11. Global Non-steroidal Anti-inflammatory Drugs Market by segment, 2018 & 2028 (USD Billion)
  • FIG 12. Global Non-steroidal Anti-inflammatory Drugs Market by segment, 2018 & 2028 (USD Billion)
  • FIG 13. Global Non-steroidal Anti-inflammatory Drugs Market by segment, 2018 & 2028 (USD Billion)
  • FIG 14. Global Non-steroidal Anti-inflammatory Drugs Market, regional snapshot 2018 & 2028
  • FIG 15. North America Non-steroidal Anti-inflammatory Drugs Market 2018 & 2028 (USD Billion)
  • FIG 16. Europe Non-steroidal Anti-inflammatory Drugs Market 2018 & 2028 (USD Billion)
  • FIG 17. Asia pacific Non-steroidal Anti-inflammatory Drugs Market 2018 & 2028 (USD Billion)
  • FIG 18. Latin America Non-steroidal Anti-inflammatory Drugs Market 2018 & 2028 (USD Billion)
  • FIG 19. Global Non-steroidal Anti-inflammatory Drugs Market, company Market share analysis (2021)
目次

Global Non-steroidal Anti-inflammatory Drugs Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Nonsteroidal anti-inflammatory medications are members of a therapeutic medicine class that lowers pain, inflammation, fever, and blood clots. The market for nonsteroidal anti-inflammatory medications (NSAIDs) is expanding due to reasons such as the increased prevalence of chronic pain throughout the world, as well as an increase in the worldwide geriatric population. Furthermore, rising demand for OTC NSAIDs and increased use of NSAIDs in headaches, migraines, toothaches, and menstrual pain are likely to drive growth throughout the projection period. The increased prevalence of chronic pain is likely to drive NSAID market growth throughout the forecast period. According to the CDC, around 20.4 percent of the adult population in the United States suffered from chronic pain in 2019. Chronic pain became more common with age, peaking in those aged 65 and more. Furthermore, the rising prevalence of arthritis and other pain-related conditions is likely to drive market expansion throughout the forecast period. According to the CDC, approximately one in every four individuals in the United States, or around 58.5 million people, has arthritis. This arthritis is more frequent in women (23.5 percent) than in males (18.1 percent ). As a result, the increased prevalence of arthritis is predicted to contribute to growth throughout the projection period. CVDs, cancer, diabetes, chronic pain, arthritis, and other illnesses are more common in the elderly population. Thus, , the growing elderly population throughout the world is likely to drive market growth. According to an Administration on Aging (AoA) study, the population aged 65 and over in the United States was roughly 54.1 million in 2019, accounting for more than 16 percent of the total population. There were around 30 million women and approximately 24.1 million males among them. By 2040, this group is predicted to account for 21.6 percent of the total in the United States. As a result, the ongoing increase in the senior population is likely to fuel growth during the predicted period. However, side effects of the drugs impede market expansion throughout the projection period of 2022-2028.

The key regions considered for the Global Non-steroidal Anti-inflammatory Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America emerged as the market leader. Some of the primary reasons driving the industry's growth are the existence of a large number of manufacturers and strategic efforts implemented by market participants. Furthermore, the rising prevalence of chronic pain and arthritis is expected to drive growth throughout the projected period. During the projection period, Asia-Pacific is predicted to be the fastest-growing region. The area's rise is ascribed to causes such as an ageing population, an increase in the prevalence of chronic pain, migraines, and headaches, as well as an increase in product approvals and launches in the region.

Major market players included in this report are:

Pfizer Inc.

Bayer AG

GSK plc

Dr. Reddy's Laboratories Ltd

Viatris Inc

Teva Pharmaceutical Industries Ltd.

Johnson And Johnson Services, Inc.

Merck & Co., Inc.

Becton Dickinson & Company

Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.)

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Disease Indication:

Arthritis

Migraine

Ophthalmic Diseases

Others

By Route of Administration:

Oral

Topical

Others

By Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Non-steroidal Anti-inflammatory Drugs Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
    • 1.2.1. Non-steroidal Anti-inflammatory Drugs Market, by Region, 2020-2028 (USD Billion)
    • 1.2.2. Non-steroidal Anti-inflammatory Drugs Market, by Disease Indication, 2020-2028 (USD Billion)
    • 1.2.3. Non-steroidal Anti-inflammatory Drugs Market, by Route of Administration, 2020-2028
    • 1.2.4. Non-steroidal Anti-inflammatory Drugs Market, by Distribution Channel, 2020-2028 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Non-steroidal Anti-inflammatory Drugs Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Non-steroidal Anti-inflammatory Drugs Market Dynamics

  • 3.1. Non-steroidal Anti-inflammatory Drugs Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising prevalence of chronic pain across the globe
      • 3.1.1.2. Increasing demand for OTC NSAIDs and the rising adoption of NSAIDs
    • 3.1.2. Market Challenges
      • 3.1.2.1. Side effects of the drugs
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Technological improvements in Non-steroidal Anti-inflammatory Drugs

Chapter 4. Global Non-steroidal Anti-inflammatory Drugs Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Non-steroidal Anti-inflammatory Drugs Market, by Disease Indication

  • 6.1. Market Snapshot
  • 6.2. Global Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, Performance - Potential Analysis
  • 6.3. Global Non-steroidal Anti-inflammatory Drugs Market Estimates & Forecasts by Disease Indication 2018-2028 (USD Billion)
  • 6.4. Non-steroidal Anti-inflammatory Drugs Market, Sub Segment Analysis
    • 6.4.1. Arthritis
    • 6.4.2. Migraine
    • 6.4.3. Ophthalmic Diseases
    • 6.4.4. Others

Chapter 7. Global Non-steroidal Anti-inflammatory Drugs Market, by Route of Administration

  • 7.1. Market Snapshot
  • 7.2. Global Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, Performance - Potential Analysis
  • 7.3. Global Non-steroidal Anti-inflammatory Drugs Market Estimates & Forecasts by Route of Administration 2018-2028 (USD Billion)
  • 7.4. Non-steroidal Anti-inflammatory Drugs Market, Sub Segment Analysis
    • 7.4.1. Oral
    • 7.4.2. Topical
    • 7.4.3. Others

Chapter 8. Global Non-steroidal Anti-inflammatory Drugs Market, by Distribution Channel

  • 8.1. Market Snapshot
  • 8.2. Global Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, Performance - Potential Analysis
  • 8.3. Global Non-steroidal Anti-inflammatory Drugs Market Estimates & Forecasts by Distribution Channel 2018-2028 (USD Billion)
  • 8.4. Non-steroidal Anti-inflammatory Drugs Market, Sub Segment Analysis
    • 8.4.1. Hospital Pharmacy
    • 8.4.2. Retail Pharmacy
    • 8.4.3. Online Pharmacy

Chapter 9. Global Non-steroidal Anti-inflammatory Drugs Market, Regional Analysis

  • 9.1. Non-steroidal Anti-inflammatory Drugs Market, Regional Market Snapshot
  • 9.2. North America Non-Steroidal Anti-inflammatory Drugs Market
    • 9.2.1. U.S. Non-steroidal Anti-inflammatory Drugs Market
      • 9.2.1.1. Disease Indication breakdown estimates & forecasts, 2018-2028
      • 9.2.1.2. Route of Administration breakdown estimates & forecasts, 2018-2028
      • 9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2018-2028
    • 9.2.2. Canada Non-steroidal Anti-inflammatory Drugs Market
  • 9.3. Europe Non-steroidal Anti-inflammatory Drugs Market Snapshot
    • 9.3.1. U.K. Non-steroidal Anti-inflammatory Drugs Market
    • 9.3.2. Germany Non-steroidal Anti-inflammatory Drugs Market
    • 9.3.3. France Non-steroidal Anti-inflammatory Drugs Market
    • 9.3.4. Spain Non-steroidal Anti-inflammatory Drugs Market
    • 9.3.5. Italy Non-steroidal Anti-inflammatory Drugs Market
    • 9.3.6. Rest of Europe Non-steroidal Anti-inflammatory Drugs Market
  • 9.4. Asia-Pacific Non-steroidal Anti-inflammatory Drugs Market Snapshot
    • 9.4.1. China Non-steroidal Anti-inflammatory Drugs Market
    • 9.4.2. India Non-steroidal Anti-inflammatory Drugs Market
    • 9.4.3. Japan Non-steroidal Anti-inflammatory Drugs Market
    • 9.4.4. Australia Non-steroidal Anti-inflammatory Drugs Market
    • 9.4.5. South Korea Non-steroidal Anti-inflammatory Drugs Market
    • 9.4.6. Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market
  • 9.5. Latin America Non-steroidal Anti-inflammatory Drugs Market Snapshot
    • 9.5.1. Brazil Non-steroidal Anti-inflammatory Drugs Market
    • 9.5.2. Mexico Non-steroidal Anti-inflammatory Drugs Market
  • 9.6. Rest of The World Non-steroidal Anti-inflammatory Drugs Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Pfizer Inc.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Disease Indication Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Bayer AG
    • 10.2.3. GSK plc
    • 10.2.4. Dr. Reddy's Laboratories Ltd
    • 10.2.5. Viatris Inc
    • 10.2.6. Teva Pharmaceutical Industries Ltd.
    • 10.2.7. Johnson And Johnson Services, Inc.
    • 10.2.8. Merck & Co., Inc.
    • 10.2.9. Becton Dickinson & Company
    • 10.2.10. Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.)

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption